Shandong Sinobioway Biomedicine Co., Ltd. (002581.SZ)
002581.SZ Stock Price Chart
Explore Shandong Sinobioway Biomedicine Co., Ltd. interactive price chart. Choose custom timeframes to analyze 002581.SZ price movements and trends.
002581.SZ Company Profile
Discover essential business fundamentals and corporate details for Shandong Sinobioway Biomedicine Co., Ltd. (002581.SZ) to support your stock research and investment decisions.
Sector
Basic Materials
Industry
Chemicals - Specialty
IPO Date
20 May 2011
Employees
476.00
Website
https://www.sdsinobioway.comCEO
Jialin Yue
Description
Shandong Sinobioway Biomedicine Co., Ltd. manufactures and supplies trimethyl orthoformate, triethyl orthoformate, trimethyl orthoacetate, phosphorous acid, ethyl formate, nerve growth factor, and alfaron in China. The company also provides NOBEX, a murine nerve growth factor for injection; Anferon, a human recombinant interferon alpha 2b injection; and Jaferon, a human recombinant interferon alpha 2b spray. In addition, it offers Healive, an inactivated hepatitis A vaccine; Bilive, a combined hepatitis A and B Vaccine; Panflu, a pandemic influenza vaccine; Anflu, a preservative-free influenza virus vaccine; Panflu.1, a Type A H1N1 influenza vaccine; etc. Further, the company exports its products to approximately 20 counties and regions in Europe and the United States. Shandong Sinobioway Biomedicine Co., Ltd. was founded in 2000 and is headquartered in Zibo, China.
002581.SZ Financial Timeline
Browse a chronological timeline of Shandong Sinobioway Biomedicine Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 22 May 2025
EPS came in at -¥0.66 , while revenue for the quarter reached ¥45.69M .
Earnings released on 31 Mar 2025
EPS came in at -¥0.06 , while revenue for the quarter reached ¥35.33M .
Earnings released on 30 Sept 2024
EPS came in at ¥0.19 , while revenue for the quarter reached ¥102.31M .
Earnings released on 30 Jun 2024
EPS came in at -¥0.00 , while revenue for the quarter reached ¥126.98M .
Earnings released on 22 May 2024
EPS came in at -¥0.04 , while revenue for the quarter reached ¥83.80M .
Earnings released on 16 Jan 2024
EPS came in at ¥0.13 , while revenue for the quarter reached ¥129.18M .
Earnings released on 31 Dec 2023
EPS came in at -¥0.55 , while revenue for the quarter reached ¥91.44M .
Earnings released on 30 Jun 2023
EPS came in at -¥0.05 , while revenue for the quarter reached ¥133.56M .
Earnings released on 31 Mar 2023
EPS came in at -¥0.03 , while revenue for the quarter reached ¥75.60M .
Earnings released on 1 Jan 2023
EPS came in at -¥0.12 , while revenue for the quarter reached ¥81.55M .
Earnings released on 30 Sept 2022
EPS came in at ¥0.06 , while revenue for the quarter reached ¥87.88M .
Earnings released on 30 Jun 2022
EPS came in at ¥0.03 , while revenue for the quarter reached ¥100.26M .
Earnings released on 31 Mar 2022
EPS came in at ¥0.01 , while revenue for the quarter reached ¥87.39M .
Earnings released on 31 Dec 2021
EPS came in at -¥0.12 , while revenue for the quarter reached ¥86.92M .
Earnings released on 30 Sept 2021
EPS came in at ¥0.32 , while revenue for the quarter reached ¥91.47M .
Earnings released on 30 Jun 2021
EPS came in at ¥0.17 , while revenue for the quarter reached ¥141.76M .
Earnings released on 29 Apr 2021
EPS came in at -¥0.14 , while revenue for the quarter reached ¥85.81M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.04 , while revenue for the quarter reached ¥82.56M .
Earnings released on 30 Sept 2020
EPS came in at -¥0.02 , while revenue for the quarter reached ¥55.07M .
002581.SZ Stock Performance
Access detailed 002581.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.